期刊文献+

血清可溶性CD146水平在早期糖尿病肾病诊断中的作用 被引量:4

Diagnostic Significance of Serum Soluble CD146 Level in Early-stage Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨血清可溶性CD146(s CDl46)水平在早期糖尿病肾病(DN)诊断中的作用。方法选用SPF级SD雄性大鼠32只,随机分为2组:空白组(C组)和模型组(DN组),每组16只。造模开始至实验结束,每周1次测量大鼠体质量、血糖,收集24 h尿液测定尿白蛋白、尿α1徽球蛋白(AIM)、尿转铁蛋白(TRU)、尿糖定性、尿N-乙酰-β-D-氨基葡萄糖苷酸(NAG)等指标。分别于成模第1天、第3周2个时间点,测定血肌酐(Scr)、血尿素氮(BUN)、s CD146水平,并计算大鼠肾质量/体质量比(RW/BW)。肾组织PAS染色观察肾皮质,计算肾小球系膜面积(MMA)。结果 DN组大鼠尿白蛋白、AIM、TRU、NAG指标明显高于C组(均P<0.01)。模型制备成功后第3周Scr、BUN指标DN组均高于C组,但差异均无统计学意义(P>0.05)。模型制备成功后第1天、第3周模型组血清s CD146水平均较C组增高(均P<0.05)。RW/BW以及肾组织PAS染色结果显示,DN组RW/BW以及MMA均高于C组(P<0.01)。结论与C组比较,DN组中血清s CD146水平较早较快增加,s CD146能够更敏感地反映肾脏损害程度,对监测DN的发生与发展有重要临床意义。 Objective To investigate serum soluble CD146 (sCD146) level in early-stage diabetic nephropathy. Methods Thirty-two SPF-class SD rats were randomly divided into 2 groups as follows : a control group (C group ,n = 16) and a model group (DN group ,n = 16). Serum creatinine (Scr), blood urea nitrogen (BUN), sCD146 level, and renal weight-to-body weight ratio (RW/BW) were estimated at the first day (D 1 ) and third week (W3) after modelling. Periodic acid-Schiff staining was used for observing the renal cortex and calculating the renal glomerular mesangial membrane area (MMA). Results The serum sCD146 level was significantly higher in the DN group at D1 and W3 (P 〈 0.05) compared with that in the C group. RW/BW and MMA were significantly higher in the DN group than in the C group (P 〈 0.01). Conclusion Serum sCD146 level reacts to increases much sooner and faster in the DN model,which could be used as a sensitive diagnostic index to reflect the severity of early renal damage.
作者 刘波 杨生
出处 《中国医科大学学报》 CAS CSCD 北大核心 2017年第11期1005-1008,共4页 Journal of China Medical University
基金 沈阳市科学技术计划(F13-316-1-32)
关键词 可溶性CD146 早期糖尿病肾病 肾脏损害 soluble CD146 early-stage diabetic nephropathy renal damage
  • 相关文献

参考文献5

二级参考文献58

  • 1王起武,查斌,王章才.CD146及肿瘤微血管密度与前列腺癌关系的研究[J].皖南医学院学报,2007,26(2):97-99. 被引量:1
  • 2Ziyadeh FN.Mediators of diabetic renal disease:The case for TGF-βas the major mediator[J].J Am Soc Nephrol,2004,15(1):55-57.
  • 3Franconi F,Seghieri G,Canu S,et al.Are the available experimental models of type2diabetes appropriate for a gender perspective[J].Pharmacol Res,2008,57(1):6-18.
  • 4Qi W,Chen X,Poronnik P,et al.Transforming growth factor-β/con nective tissue growth factor axis in the kidney[J].Int J Biochem Cell Biol,2008,40(1):9-13.
  • 5Brigstock DR.The CCN family:a new stimulus package[J].J Endocri nol,2003,178(2):169-175.
  • 6Shi-wen X,Stanton LA,Kennedy L,et al.CCN2is necessary for ad hesive responses to transforming growth factor-beta1in embryonic fibroblasts[J].J Biol Chem,2006,281(16):10715-10726.
  • 7Leask A.Targeting the TGF-beta,endothelin-1and CCN2axis to combat fibrosis in scleroderma[J].Cell Signal,2008,20(8):1409-1414.
  • 8Otsu H,Can H,Spentzs D,et al.Prediction of diabetic nephropathy using urine proteomic profiling10years prior to development of ne phropathy[J].Diabetes Care,2007,30(2):638-643.
  • 9Gilbert RE,Akdeniz A,Weitz S,et al.Urinary connective tissue growth factor excretion in patients with type1diabetes and nephrop athy[J].Diabetes Care,2003,26(9):2632-2636.
  • 10Jerums G,Premaratne E,Panagiotopoulos S,et al.New and old markers of progression of diabetic nephropathy[J].Diabetes Res Clin Pract,2008,82(Suppl1):30-37.

共引文献38

同被引文献35

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部